FDMT · Categories · 8-K

FDMT - SEC Form 8-K filings

4D Molecular Therapeutics Inc. (FDMT) sec form 8-k filings - real-time wire coverage filtered to 8-K only.

Recent 8-K for FDMT

• 32d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 70d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Leadership Update

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 82d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 133d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 153d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 180d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Other Events

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 204d
  SEC Form 8-K filed by 4D Molecular Therapeutics Inc.

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 211d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 213d
  SEC Form 8-K filed by 4D Molecular Therapeutics Inc.

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 215d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 221d
  SEC Form 8-K filed by 4D Molecular Therapeutics Inc.

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 249d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 302d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 341d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Other Events

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 353d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 396d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 465d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 484d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Other Events

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 515d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 544d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 572d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 628d
  SEC Form 8-K filed by 4D Molecular Therapeutics Inc.

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 669d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 686d
  SEC Form 8-K filed by 4D Molecular Therapeutics Inc.

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 692d
  SEC Form 8-K filed by 4D Molecular Therapeutics Inc.

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 731d
  SEC Form 8-K filed by 4D Molecular Therapeutics Inc.

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 745d
  SEC Form 8-K filed by 4D Molecular Therapeutics Inc.

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 760d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 830d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 850d
  SEC Form 8-K filed by 4D Molecular Therapeutics Inc.

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 887d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Leadership Update

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 929d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 942d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 1000d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Leadership Update

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 1034d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 1064d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 1110d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 1126d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 1181d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 1229d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Other Events

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 1307d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 1350d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Leadership Update

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 1397d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 1452d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 1473d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

  8-K - 4D Molecular Therapeutics, Inc. (0001650648) (Filer)
• 1488d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics Inc. (0001650648) (Filer)
• 1533d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics Inc. (0001650648) (Filer)
• 1567d
  4D Molecular Therapeutics Inc. filed SEC Form 8-K: Leadership Update

  8-K - 4D Molecular Therapeutics Inc. (0001650648) (Filer)
• 1610d
  4D Molecular Therapeutics, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics Inc. (0001650648) (Filer)
• 1671d
  4D Molecular Therapeutics, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics Inc. (0001650648) (Filer)
• 1687d
  4D Molecular Therapeutics, Inc. filed SEC Form 8-K: Other Events

  8-K - 4D Molecular Therapeutics Inc. (0001650648) (Filer)
• 1699d
  4D Molecular Therapeutics, Inc. filed SEC Form 8-K: Other Events

  8-K - 4D Molecular Therapeutics Inc. (0001650648) (Filer)
• 1718d
  4D Molecular Therapeutics, Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics Inc. (0001650648) (Filer)
• 1761d
  SEC Form 8-K filed by 4D Molecular Therapeutics, Inc.

  8-K - 4D Molecular Therapeutics Inc. (0001650648) (Filer)
• 1809d
  SEC Form 8-K filed by 4D Molecular Therapeutics, Inc.

  8-K - 4D Molecular Therapeutics Inc. (0001650648) (Filer)
• 1845d
  4D Molecular Therapeutics, Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

  8-K - 4D Molecular Therapeutics Inc. (0001650648) (Filer)
• 1852d
  4D Molecular Therapeutics, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

  8-K - 4D Molecular Therapeutics Inc. (0001650648) (Filer)
• 1901d
  SEC Form 8-K filed by 4D Molecular Therapeutics, Inc.

  8-K - 4D Molecular Therapeutics Inc. (0001650648) (Filer)

Other FDMT categories

• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends